4:06 PM ET
8-K
Other 8-K Filing
Pasithea Therapeutics Other 8-K Filing
Pasithea Therapeutics Corp. announced that its warrants (KTTAW) will expire on September 17, 2026, and will subsequently be delisted from The Nasdaq Capital Market. Any warrants not exercised prior to the expiration date will cease to be exercisable and will have no further value. The company's common stock (KTTA) will continue to trade on Nasdaq.